شنبه 1 شهریور 1404
[Archive]
پذیرفته شده و در حال انتشار
برگشت به فهرست مقالات |
برگشت به فهرست نسخه ها
چکیده: (244 مشاهده)
One of the most common complications of diabetes, which places a significant economic burden on both patients and society, is diabetic peripheral neuropathy. Managing diabetic neuropathy is challenging due to the limited availability of effective treatment options. In recent years, numerous studies have shown that topical herbal medicines can alleviate neurological symptoms. Therefore, these products, which offer significant analgesic effects with minimal side effects, have been used to treat patients with this condition. This paper reviews six types of topical herbal medicines with analgesic effects on diabetic neuropathy and provides insights for researchers aiming to design and develop effective topical herbal treatments.
نوع مطالعه: مقاله مروری |
موضوع مقاله:
Pharmacology
دریافت: 1403/12/21 | پذیرش: 1404/5/1 | انتشار: 1404/5/17
دریافت: 1403/12/21 | پذیرش: 1404/5/1 | انتشار: 1404/5/17
فهرست منابع
1. Yang XD, Fang PF, Xiang DX, Yang YY. Topical treatments for diabetic neuropathic pain. Exp Ther Med. 2019;17(3):1963-76. [DOI:10.3892/etm.2019.7173] [PMID] [PMCID]
2. Ebrahimi F, Farzaei MH, Bahramsoltani R, Heydari M, Naderinia K, Rahimi R. Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence. Rev Neurosci. 2019;30(6):671-84. [DOI:10.1515/revneuro-2018-0097] [PMID]
3. Price R, Smith D, Franklin G, Gronseth G, Pignone M, David WS, et al. Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN guideline subcommittee. Neurology. 2022;98(1):31-43. [DOI:10.1212/WNL.0000000000013038] [PMID]
4. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120(1):1-34.
https://doi.org/10.1016/j.pharmthera.2008.05.005 [DOI:10.1016/j.pharmthera.2008.09.003] [PMID] [PMCID]
5. Yammine K, Abi Kharma J, Kaypekian T, Assi C, Zeeni N. Is diabetic neuropathy associated with vitamin D status?. A meta-analysis. Br J Nutr. 2022;127(7):972-81. [DOI:10.1017/S0007114521001707] [PMID]
6. Petersen EA, Stauss TG, Scowcroft JA, Brooks ES, White JL, Sills SM, et al. Durability of high-frequency 10-kHz spinal cord stimulation for patients with painful diabetic neuropathy refractory to conventional treatments: 12-month results from a randomized controlled trial. Diabetes Care. 2022;45(1):e3-e6.
7. Kharitonova T, Shvarts YG, Verbovoy AF, Orlova NS, Puzyreva VP, Strokov IA. Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER). BMJ Open Diabetes Res Care. 2022;10(3):e002785. [DOI:10.1136/bmjdrc-2022-002785] [PMID] [PMCID]
8. Mabley JG, Soriano FG. Role of nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic vascular dysfunction. Curr Vasc Pharmacol. 2005;3(3):247-52. [DOI:10.2174/1570161054368571] [PMID]
9. Forouzanfar F, Hosseinzadeh H. Medicinal herbs in the treatment of neuropathic pain: a review. Iran J Basic Med Sci. 2018;21(4):347-58.
10. Khodaie S-A, Nikkhah H, Namiranian N, Abotorabi M, Askari M, Khalilzadeh SH, et al. Topical Nigella sativa L. product: A new candidate for the management of diabetic peripheral neuropathy. Inflammopharmacology. 2023;32:551-9. [DOI:10.1007/s10787-023-01338-2] [PMID]
11. Ardeleanu V, Toma A, Pafili K, Papanas N, Motofei I, Diaconu CC, et al. Current pharmacological treatment of painful diabetic neuropathy: A narrative review. Medicina. 2020;56(1):25. [DOI:10.3390/medicina56010025] [PMID] [PMCID]
12. Sawynok J. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. Eur J Pain. 2014;18(4):465-81. [DOI:10.1002/j.1532-2149.2013.00400.x] [PMID]
13. Zur E. Topical treatment of neuropathic pain using compounded medications. Clin J Pain. 2014;30(1):73-91. [DOI:10.1097/AJP.0b013e318285d1ba] [PMID]
14. Vaghasloo MA, Aliasl F, Mohammadbeigi A, Bitarafan B, Etripoor G, Asghari M. Evaluation of the efficacy of warm salt water foot-bath on patients with painful diabetic peripheral neuropathy: A randomized clinical trial. Complement Ther Med. 2020;49:102325. [DOI:10.1016/j.ctim.2020.102325] [PMID]
15. Heydari M, Shams M, Hashempur MH, Zargaran A, Dalfardi B, Borhani-Haghighi A. The origin of the concept of neuropathic pain in early medieval Persia (9th-12th century CE). Acta Med Hist Adriat. 2015;13:9-22.
16. Setayesh M, Zargaran A, Sadeghifar AR, Salehi M, Rezaeizadeh H. New candidates for treatment and management of carpal tunnel syndrome based on the Persian Canon of Medicine. Integr Med Res. 2018;7(2):126-35. [DOI:10.1016/j.imr.2018.02.003] [PMID] [PMCID]
17. Esmaeilpour HR, Boostani R, Shoeibi A, Bazzaz M, Salari R, Yousefi M. The potential effects of Caper (Capparis spinosa L.) in the treatment of diabetic neuropathy. Tradit Med Res. 2020;5(6):442-8. [DOI:10.53388/TMR20200223167]
18. Vileikyte L, Leventhal H, Gonzalez JS, Peyrot M, Rubin RR, Ulbrecht JS, et al. Diabetic peripheral neuropathy and depressive symptoms: the association revisited. Diabetes Care. 2005;28(10):2378-83. [DOI:10.2337/diacare.28.10.2378] [PMID]
19. Abdolmaleki A, Akram M, Saeed MM, Asadi A, Kajkolah M. Herbal medicine as neuroprotective potential agent in human and animal models: A historical overview. J Pharm Care. 2020;8(2):75-82. [DOI:10.18502/jpc.v8i2.3832]
20. Heydari M, Hashempur MH, Mosvat SH. Herbal remedies for neuropathic pain in Traditional Persian Medicine. Planta Med. 2015;81(16):PW_117. [DOI:10.1055/s-0035-1565741]
21. Mou J, Paillard F, Turnbull B, Trudeau J, Stoker M, Katz NP. Qutenza (capsaicin) 8% patch onset and duration of response and effects of multiple treatments in neuropathic pain patients. Clin J Pain. 2014;30(4):286-94. [DOI:10.1097/AJP.0b013e31829a4ced] [PMID]
22. Rosenberg CJ, Watson JC. Treatment of painful diabetic peripheral neuropathy. Prosthet Orthot Int. 2015;39(1):17-28. [DOI:10.1177/0309364614542266] [PMID]
23. Bril V, England JD, Franklin GM, Backonja M, Cohen JA, Del Toro DR, et al. Evidence‐based guideline: Treatment of painful diabetic neuropathy-report of the american association of neuromuscular and electrodiagnostic medicine, the american academy of neurology, and the american academy of physical medicine & rehabilitation. Muscle Nerve. 2011;43(6):910-7. [DOI:10.1002/mus.22092] [PMID]
24. Biesbroeck R, Bril V, Hollander P, Kabadi U, Schwartz S, Singh S, et al. A double-blind comparison of topical capsaicin and oral amitriptyline in painful diabetic neuropathy. Adv Ther. 1995;12(2):111-20.
25. Tandan R, Lewis GA, Krusinski PB, Badger GB, Fries TJ. Topical capsaicin in painful diabetic neuropathy: controlled study with long-term follow-up. Diabetes Care. 1992;15(1):8-14.
https://doi.org/10.2337/diacare.15.1.8 [DOI:10.2337/diacare.15.1.15] [PMID]
26. Simpson DM, Robinson-Papp J, Van J, Stoker M, Jacobs H, Snijder RJ, et al. Capsaicin 8% patch in painful diabetic peripheral neuropathy: a randomized, double-blind, placebo-controlled study. J Pain. 2017;18(1):42-53. [DOI:10.1016/j.jpain.2016.09.008] [PMID]
27. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, et al. Does capsaicin relieve the pain of diabetic neuropathy? Pain. 1990;42(3):387-8. [DOI:10.1016/0304-3959(90)91153-A] [PMID]
28. Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double‐blind, crossover, placebo‐controlled trial. Pain Pract. 2013;13(6):497-503. [DOI:10.1111/papr.12013] [PMID]
29. Zhao Q, Liu C, Shen X, Xiao L, Wang H, Liu P, et al. Cytoprotective effects of myristicin against hypoxia‑induced apoptosis and endoplasmic reticulum stress in rat dorsal root ganglion neurons. Mol Med Rep. 2017;15(4):2280-8. [DOI:10.3892/mmr.2017.6258] [PMID]
30. Lim H-S, Kim B-Y, Kim YJ, Jeong S-J. Phytochemical allylguaiacol exerts a neuroprotective effect on hippocampal cells and ameliorates scopolamine-induced memory impairment in mice. Behav Brain Res. 2018;339:261-8. [DOI:10.1016/j.bbr.2017.11.003] [PMID]
31. Motilal S, Maharaj RG. Nutmeg extracts for painful diabetic neuropathy: a randomized, double-blind, controlled study. J Altern Complement Med. 2013;19(4):347-52. [DOI:10.1089/acm.2012.0016] [PMID]
32. Marzouk B, Marzouk Z, Haloui E, Fenina N, Bouraoui A, Aouni M. Screening of analgesic and anti-inflammatory activities of Citrullus colocynthis from southern Tunisia. J Ethnopharmacol. 2010;128(1):15-9. [DOI:10.1016/j.jep.2009.11.027] [PMID]
33. Heydari M, Homayouni K, Hashempur MH, Shams M. Topical C itrullus colocynthis (bitter apple) extract oil in painful diabetic neuropathy: A double‐blind randomized placebo‐controlled clinical trial. J Diabetes. 2016;8(2):246-52. [DOI:10.1111/1753-0407.12287] [PMID]
34. Andre CM, Hausman JF, Guerriero G. Cannabis sativa: the plant of the thousand and one molecules. Front Plant Sci. 2016;7:19. [DOI:10.3389/fpls.2016.00019] [PMID] [PMCID]
35. Selvarajah D, Gandhi R, Emery CJ, Tesfaye S. Randomized placebo-controlled double-blind clinical trial of cannabis-based medicinal product (Sativex) in painful diabetic neuropathy: depression is a major confounding factor. Diabetes Care. 2010;33(1):128-30. [DOI:10.2337/dc09-1029] [PMID] [PMCID]
36. Razavi BM, Ghasemzadeh Rahbardar M, Hosseinzadeh H. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents. Phytother Res. 2021;35(12):6489-513. [DOI:10.1002/ptr.7224] [PMID]
37. Sanaa G, MIA I, Said EM, Ahmed I EM. Topical capsaicin-curcumin combination: an effective therapy for chronic painful distal symmetric polyneuropathy in diabetic patients. J Egypt Soc Endocrinol Metab Diabetes. 2002;34(1-2):93-8.
38. Javidi S, Razavi BM, Hosseinzadeh H. A review of Neuropharmacology Effects of Nigella sativa and Its Main Component, Thymoquinone. Phytother Res. 2016;30(8):1219-29. [DOI:10.1002/ptr.5634] [PMID]
39. Khodaie SA, Nikkhah H, Namiranian N, Abotorabi M, Askari M, Khalilzadeh SH, et al. Topical Nigella sativa L. product: a new candidate for the management of diabetic peripheral neuropathy. Inflammopharmacology. 2024 Feb;32(1):551-9. [DOI:10.21203/rs.3.rs-1840679/v1] [PMCID]
40. Khodaie SA, Razavi R, Nikkhah H, Namiranian N, Kamalinejad M. Nigella sativa L. and its bioactive and nutraceutical components in the management of diabetic peripheral neuropathy. Inflammopharmacology. 2024;32(5):2897-920. [DOI:10.1007/s10787-024-01528-6] [PMID]
41. Huseini HF, Kianbakht S, Mirshamsi MH, Zarch AB. Effectiveness of topical Nigella sativa seed oil in the treatment of cyclic mastalgia: a randomized, triple-blind, active, and placebo-controlled clinical trial. Planta Med. 2016;82(4):285-8. [DOI:10.1055/s-0035-1558208] [PMID]
42. Hashempur MH, Homayouni K, Ashraf A, Salehi A, Taghizadeh M, Heydari M. Effect of Linum usitatissimum L.(linseed) oil on mild and moderate carpal tunnel syndrome: a randomized, double-blind, placebo-controlled clinical trial. Daru. 2014;22(1):43. [DOI:10.1186/2008-2231-22-43] [PMID] [PMCID]
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
